Absorption |
Water solubility (log mol/L) |
−1.88 |
−2.24 |
−3.1 |
−2.01 |
−4.12 |
−3.561 |
−2.929 |
−3.808 |
−4.441 |
−2.97 |
Caco2 permeability (log Papp in 10−6 cm/s) |
0.14 |
−0.31 |
−0.17 |
−0.49 |
0.67 |
1.337 |
1.027 |
1.21 |
1.376 |
0.108 |
Intestinal absorption (human) (% Absorbed) |
42.81 |
32.3 |
45 |
25.50 |
93.15 |
95.325 |
96.606 |
96.34 |
91.364 |
61.309 |
P-glycoprotein substrate (Yes/No) |
NO |
Yes |
Yes |
Yes |
Yes |
No |
No |
Yes |
No |
No |
Distribution |
BBB permeability (log BB) |
−0.71 |
−1.007 |
−1.38 |
−1.09 |
−0.04 |
−0.007 |
−0.313 |
0.142 |
0.098 |
−0.953 |
CNS permeability (log PS) |
−3.18 |
−4.15 |
−3.80 |
−3.92 |
−2.132 |
−2.176 |
−2.333 |
−2.135 |
−3.22 |
−3.414 |
Metabolism |
CYP2D6 substrate (Yes/No) |
No |
No |
No |
No |
No |
No |
No |
Yes |
No |
No |
CYP3A4 substrate (Yes/No) |
No |
No |
No |
No |
Yes |
Yes |
Yes |
Yes |
No |
No |
CYP1A2 inhibitor (Yes/No) |
No |
No |
No |
No |
Yes |
No |
No |
No |
No |
No |
CYP2C19 inhibitor (Yes/No) |
No |
No |
No |
No |
No |
No |
No |
No |
Yes |
No |
CYP2C9 inhibitor (Yes/No) |
No |
No |
No |
No |
No |
No |
No |
No |
No |
No |
CYP2D6 inhibitor (Yes/No) |
No |
No |
No |
No |
No |
No |
No |
No |
No |
No |
CYP3A4 inhibitor (Yes/No) |
No |
No |
No |
No |
No |
No |
No |
No |
No |
No |
Excretion |
Total Clearance (log mL/min/kg) |
0.93 |
1.04 |
0.225 |
0.524 |
0.196 |
1.101 |
0.506 |
0.762 |
−0.374 |
1.05 |
Renal OCT2 substrate (Yes/No) |
No |
No |
No |
No |
No |
Yes |
No |
Yes |
No |
No |
Toxicity |
AMES toxicity (Yes/No) |
No |
No |
No |
No |
No |
No |
No |
No |
No |
No |
Max. tolerated dose (human) (log mg/kg/day) |
0.89 |
1.50 |
0.847 |
−0.224 |
0.039 |
−0.465 |
0.2 |
−0.741 |
0.171 |
0.906 |
hERG I inhibitor (Yes/No) |
No |
No |
No |
No |
No |
No |
No |
No |
No |
No |
Hepatotoxicity (Yes/No) |
Yes |
Yes |
Yes |
No |
Yes |
No |
No |
No |
No |
Yes |